Avita Medical Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Avita Medical Inc. (RCEL) holds an ST Score of 55.9 out of 100 (B-), with its strongest factor being Valuation (A-) and its weakest Financial Strength (C). Analysts rate RCEL Buy across 8 ratings with a $11.00 average price target (-0.0% vs the current $11.02).
- Strongest
- ValuationA-
- Weakest
- Financial StrengthC
All factor grades
- ValuationA-
- MomentumA-
- GrowthB+
- ProfitabilityC+
- ForecastC+
- Financial StrengthC
- Piotroski3/9
Contact
RCEL stock: frequently asked questions
What is RCEL's ST Score?
Avita Medical Inc. (RCEL) has an ST Score of 55.9 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is RCEL a buy, sell, or hold?
Wall Street's consensus rating on RCEL is Buy based on 8 analyst ratings. Our own ST Score grades it B- (55.9/100). This is data, not investment advice — always do your own research.
What is RCEL's valuation grade?
Avita Medical Inc. (RCEL) earns a valuation grade of A-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is RCEL's growth grade?
Avita Medical Inc. (RCEL) earns a growth grade of B+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is RCEL's profitability grade?
Avita Medical Inc. (RCEL) earns a profitability grade of C+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is RCEL's financial strength grade?
Avita Medical Inc. (RCEL) earns a financial strength grade of C, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for RCEL?
The average analyst price target for Avita Medical Inc. (RCEL) is $11.00 from 8 analysts, which is -0.0% versus the recent price of $11.02.
What is RCEL's Piotroski score?
Avita Medical Inc. (RCEL) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.